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INTRODUCTION
Chronic obstructive pulmonary disorder (COPD) is one of the
major diseases that afflict smokers and the fourth leading cause of
death in the United States and Europe.1 Infection with a nontype-
able strain of Haemophilus influenzae (NTHi) often exacerbates
COPD. Furthermore, the NTHi strain is responsible for 30% of
acute otitis media cases (middle ear infections), which afflict
greater than 75% of children at some time during childhood.
NTHi are Gram-negative bacteria with an outer membrane con-
taining short lipopolysaccharides, but lacking the extracellular cap-
sule found in the more virulent type b strain of H. influenzae. As
obligate parasites of humans, NTHi bacteria commonly inhabit the
respiratory tracts of healthy individuals and have no identified
growth environment outside of the host. Because strains of
H. influenzae have relatively small genomes (about one-third the size
of the E. coli K12 genome), and lack genes essential for heme biosyn-
thesis, they must transport heme and NAD from the host.
Increasing resistance to antimicrobials as well as the lack of an
NTHi vaccine are stimulating the effort to find new drug targets
or antigens suitable for a potential vaccine. Preferably, target
antigens should be surface-exposed and functionally essential to
minimize antigenic drift. After screening the genome of the non-
encapsulated H. influenzae Rd strain by in vitro transposon mu-
tagenesis, Akerley et al. identified 478 open reading frames, rep-
resenting 38% of the genome, that were critical for growth or vi-
ability on rich medium.2 Of these genes, 259 were annotated as
encoding proteins of unknown function of which 159 were also
found in other bacterial species. Such genes may encode proteins
important for basic cellular metabolism.
One of the essential genes is yraM (HI1655) that encodes a
575-residue secreted lipoprotein of unknown function. The
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ABSTRACT
Nontypeable Haemophilus influenzae is an obligate
human parasite that often causes middle ear infec-
tions in children and exacerbates chronic obstructive
pulmonary disorder, the fourth leading cause of death
in the United States. There are no effective vaccines
available for this strain. The lipoprotein YraM (gene
HI1655) was identified as essential for the growth
and viability of H. influenzae but its function is
unknown. Sequence comparisons showed that YraM
is a fusion of two protein modules. We grew crystals
of the carboxyl-terminal module of YraM comprising
residues 257–573 (YraM-C), phased the diffraction
data by the multiwavelength anomalous diffraction
technique, and refined the model to a crystallographic
R-factor of 0.16 (Rfree 5 0.19) with data to 1.35 Å re-
solution. The two-domain structure of YraM-C adopts
a fold similar to that observed for the open, unli-
ganded forms of several periplasmic binding proteins
(PBPs) involved in bacterial active transport.
Sequence alignments of YraM homologues from other
Gram-negative species showed that the most con-
served residues of YraM-C cluster between the two
domains in the location where other PBPs bind their
cognate ligand. Modeling of YraM-C into a closed
conformation similar to the leucine-bound form of
the Leu/Ile/Val-binding protein (LIVBP) shows a puta-
tive binding pocket larger than the leucine-binding
site in LIVBP. The pocket has both polar and nonpo-
lar surfaces, with the latter located in the same area
where a leucine side chain binds to LIVBP. We discuss
possible biological functions of YraM considering its
predicted location in the outer membrane, a novel
place for such a binding protein.
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PFAM3 22.0 database entry PF04348 aligns YraM homo-
logues from 116 distinct species of proteobacteria. The
homologues are 20–62% identical to full-length YraM at
the protein level. Following a hydrophobic signal sequence
is the characteristic motif of -LAGCS- found in bacterial
lipoproteins.4 Lipoproteins of this type are translocated
into the periplasm, modified with diacylglycerol on the
conserved cysteine thiol (Cys26 in YraM), and proteolyzed
by signal peptidase II just before the modified cysteine.
The new N-terminus is then acylated to tether the protein
to the membrane. In YraM, the serine following Cys26
directs the protein for translocation to the outer mem-
brane.5 Membrane fractionation and LC/MS analysis of
the E. coli proteome showed that YraM is expressed and
localizes to the outer membrane.6 Although we detect H.
influenzae YraM in membrane fractions (unpublished
data), precisely which membrane has yet to be confirmed.
The growth dependency of H. influenzae Rd on yraM
was verified by controlled expression of the gene under
the control of the xylose promoter.4 Substitution of Gly
for Asp522, an invariant residue in all YraM homologues,
renders the resulting H. influenzae mutant strain temper-
ature sensitive. This temperature sensitive mutation is re-
cessive, indicating that the substitution conditionally
inactivates YraM function.4 Experiments described for
Pseudomonas aeruginosa and E. coli mutants showed that
the yraM orthologs were not essential in these species,
suggesting that bacteria with larger genomes might
encode other proteins with complementary function.7,8
Although an effective vaccine exists for the encapsulated
type b serotype of the bacterium, there is none for the non-
typeable strains. The outer membrane location and essential
function of YraM make it a potential vaccine antigen for H.
influenzae. In fact, the antigenicity of a putative YraM
homologue from Mannheimia haemolytica A1 (GS60, 33%
identical to H. influenzae YraM) was correlated with the
protective efficacy of a commercial bovine vaccine against
this bacterium.9 Additionally, the YraM homologue in
Edwardsiella tarda is antigenic in fish10 and LppC (67%
identical to NTHi YraM) from Haemophilus somnus was re-
active to bovine serum from infected animals.11
We report here that YraM is comprised of two distinct
structural modules. With the goal of understanding the
function of H. influenzae YraM, we describe the crystal
structure to 1.35 Å resolution of the carboxyl-terminal
portion of YraM (residues 257–573), and show it to be
very similar to the family of bacterial periplasmic binding
proteins (PBPs).
METHODS
Expression and purification of residues
257–573 of YraM
Restriction enzymes and polymerases for PCR were pur-
chased from Invitrogen, Promega, and New England Bio-
Labs and used according to the manufacturer’s directions.
Oligonucleotides were synthesized by Sigma Genosys, and
plasmids and PCR fragments were purified with kits from
Qiagen. Inserts cloned into plasmids were sequenced at
the University of Michigan DNA sequencing facility in
both directions to ensure error-free amplification.
Results of PSI-Blast sequence comparisons (see
Results) suggested that the fragment corresponding to
the PBP-like fold was between residues 257 and 575 of
H. influenzae YraM. The 951 base pair gene fragment
corresponding to Ser257-Val573 was amplified by PCR
from genomic DNA isolated from the nonencapsulated
H. influenzae Rd strain derivative of ATCC #9008. This
gene sequence was almost identical to that present in a
clinical isolate of a true NTHi strain, 86-029NP. Sequen-
ces of the primer oligonucleotides were 50-CATGC-
CATGGTGTCACAAATTGGTTTACTCTTG-30 (forward)
and 50-GCCGACGTCGACAACTGGTACAATTGCACCATC-
30 (reverse), which added NcoI and SalI sites to the 50
and 30 ends, respectively. The amplified fragment was
cleaved with NcoI and SalI and ligated with T4 DNA
ligase into the pETBlueTM-2 vector (Novagen/EMD) that
had been opened with NcoI and XhoI. Ligation products
were transformed into E. coli NovaBlue competent cells.
The resulting plasmid encoded the sequence Met-Val-
YraM(Ser257-Val573)-Val-Asp-6(His), referred within as
YraM-C.
To express soluble, folded protein, the plasmid was
transformed into E. coli OrigamiTM(DE3)-pLacI compe-
tent cells (Novagen), a strain that contains mutations to
enhance disulfide bond formation in the cytoplasm
(YraM-C has one disulfide). One liter of LB medium
supplemented with ampicillin (100 lg/mL) was inocu-
lated with 10 mL of an overnight culture, and incubated
at 378C with shaking until OD600 5 0.7. IPTG was added
to a final concentration of 1 mM and growth was contin-
ued overnight at 258C. Cells were harvested by centrifu-
gation at 3000g for 10 min. To make protein with seleno-
methionine (SeMet) in place of methionine, YraM-C was
expressed as above except that before induction, when
the OD600 reached 0.6, cells were centrifuged, washed,
and resuspended in M9 minimal media12 supplemented
with amino acids (except Met) and 80 lg/mL SeMet.
Wild type YraM-C and YraM-C(SeMet) were then
purified by the same protocol. The cell pellet was resus-
pended in 50 mL of buffer A (50 mM sodium phosphate
pH 8.0, 300 mM NaCl, 1 mM imidazole) containing an
EDTA-free protease inhibitor cocktail tablet (Roche).
Cells were sonicated and centrifuged at 48C for 1 hr at
30,000g. The supernatant was added to Ni21-NTA aga-
rose (Qiagen) and incubated with gentle rocking for 1 hr
at 48C. The lysate/Ni21-NTA mixture was loaded into a
column and washed with buffer A, with increasing con-
centrations of imidazole up to 20 mM. Protein was
eluted with buffer containing 300 mM imidazole and an-
alyzed by SDS-PAGE. The purified protein was dialyzed
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overnight at 48C against a large volume of buffer
(20 mM Tris pH 8.0, 1 mM EDTA, and 0.1 mM benza-
midine) containing 0.1% b-mercaptoethanol (BME). The
dialyzed protein was further purified on a MonoQ-10/
100 column (Amersham) and eluted with a 0–1.0M NaCl
gradient in the above buffer containing 2 mM dithiothre-
itol (DTT). Protein eluted between 60 and 100 mM
NaCl. The protein was concentrated to 10 mg/mL in 20
mL ApolloTM (10-kDa cutoff) concentrators (Orbital
Biosciences) and stored at 2208C.
Crystallization and data collection
Native YraM-C crystals grew as thin, needle clusters at
228C in a drop containing 2 lL of 10 mg/mL protein so-
lution and precipitant comprised of 2 lL 3.4M Na for-
mate and 0.4 lL 0.1M DTT. The drop was equilibrated
by vapor diffusion against 1 mL of precipitant containing
0.05% BME. Crystals grew to a maximum size of 0.8 3
0.1 3 0.1 mm3 and were in the hexagonal space group
P65, with cell dimensions a 5 b 5 117.2 Å, c 5 115.1 Å
and two molecules per asymmetric unit. For cryoprotec-
tion, 20 lL of a precipitant containing 3.4M Na formate,
45 mM NaCl, and 0.05% BME with 50% saturated Li
formate solution was added to the crystals immediately
before freezing in liquid nitrogen.
The YraM-C(SeMet) protein crystallized at 228C in a
hanging drop containing 2 lL of protein and 2 lL of pre-
cipitant containing unbuffered 1.0M lithium sulfate, 2%
(w/v) polyethylene glycol 8000, and 0.05% BME. The thin
plate-like crystals reached a maximum size of 0.8 3 0.3 3
0.04 mm3 and belonged to the monoclinic space group C2,
with cell dimensions a 5 109.9 Å, b 5 50.65 Å, c 5 63.66 Å,
and b 5 106.88 and one molecule per asymmetric unit.
For data collection, crystals were transferred to precipitant
containing 25% glycerol and frozen in liquid nitrogen.
Diffraction intensities were measured for both crystal
forms at DND-CAT (beamline 5-ID), Advanced Photon
Source, Argonne, IL. Friedel pairs at three wavelengths
were measured from a single SeMet crystal by the inverse
beam method. Reflection intensities were integrated and
scaled by d*TREK13 (Rigaku/MSC). Intensity statistics
for native and SeMet crystals are shown in Table I
Structure solution and refinement
Data from the monoclinic SeMet data were phased to
1.8 Å by the multiwavelength anomalous diffraction
method as implemented in SOLVE16 (Table I). The
RESOLVE program17 improved electron density maps by
maximum-likelihood density modification, and located
several a-helices of the structure. The remainder of the
structure was modeled with O.18 The SeMet-containing
YraM-C model was refined by slow-cool simulated
annealing (torsion dynamics, starting temperature 5
3000 K) in CNS,19 and finally with Cartesian dynamics
(1500 K), with a bulk solvent correction applied. Because
of its higher resolution, we chose to refine the model
against the peak wavelength anomalous data diffraction
data (0.97843 Å, f 0 5 28.13 and f @ 5 5.05). After each
round of refinement, rA-weighted 2mFO-DFC and mFO-
DFC maps were calculated with model phases for interac-
tive model building. Upon reaching convergence at Rwork 5
0.207 (Rfree 5 0.227) with CNS, the model was refined
with restrained anisotropic thermal displacement parame-
ters (ADPs) to a final Rwork of 0.16 (Rfree 5 0.19) for all
data to 1.35 Å using the programs REFMAC20 and
Coot.21 Weights were adjusted to obtain a root mean
square deviation from ideality of 0.016 Å for bond
lengths. All non-glycine residues were found in the
allowed regions of a Ramachandran plot. Difference
peaks were assigned to water molecules if the density in
2mFO-DFC maps was above 1 r over the mean, and
formed at least one hydrogen bond to another atom. The
final structure includes residues 257–574, 333 water mol-
ecules, one sulfate anion, and one unknown molecule
modeled as BME (details in Table I). Eight of the resi-
dues had poor electron density; atoms from most of
these were set to zero occupancy (see Results). Alternate
conformations for 13 side chains were also observed. The
mean anisotropy of the ADPs for all protein atoms was
0.67.15 The model coordinates and structure factors are
available from the Protein Data Bank22 as entry 3CKM.
Diffraction data from the hexagonal crystal form of
native YraM-C was phased by molecular replacement
with CNS19 and the SeMet structure as the search
model, and partially refined to 2.7 Å (results not shown).
Refinements were discontinued at this point since the
model showed the same open conformation as observed
in the high-resolution monoclinic structure.
RESULTS
Sequence analyses of YraM
YraM, encoded by the Haemophilus influenzae Rd
HI1655 gene, is a 575-residue secreted polypeptide that,
after processing, is a 60.6 kDa lipoprotein acylated at the
N-terminal Cys26. PSORTb predicts that the protein is
not retained on the inner membrane but is tethered to
the outer membrane because the residue following Cys26
is Ser and not Asp.23 PSI-Blast24 searches of the non-
redundant protein sequence library with the YraM
sequence (Genbank accession code AAC23299) showed
homology to two different families of molecules, suggest-
ing that YraM may contain two distinct protein modules.
A search with the amino-terminal region, comprising res-
idues 33–256 (YraM-N), detected YraM orthologs but
also several bacterial proteins of known function at a
lower significance level (E > 1024): the amino-terminal
portion of HemY, a membrane associated protein
involved in protoheme biosynthesis;25 the amino-termi-
J. Vijayalakshmi et al.
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nal domains of the cellulose synthase operon C protein,
an outer membrane protein;26 a periplasmic protein
annotated as a soluble lytic murein transglycosylase; and
PilF involved in pilus formation.27 All of these are peri-
plasmic proteins and contain tetracopeptide-like repeats
(TPRs). TPRs are 34-residue motifs, each forming two
antiparallel helices, and often arranged sequentially to
form a superhelix of helices.28 Such domains mediate
protein-protein interactions in vesicle transport, protein
translocation, protein phosphorylation, and glycosyla-
Table I




(beamline 5ID, DND-CAT, APS) (DND, APS)
Unit cell () a 5 109.9, b 5 50.65, c 5 63.66, b 5 106.88 a 5 b 5 117.2, c 5 115.08
Space Group C 2 P 65
Wavelength () 0.97857 0.97843 (peak) 0.96321 1.0
Resolutiona () 47.1–1.4 (1.45–1.4) 47.1–1.35 (1.4–1.35) 47.1–1.45 (1.5–1.45) 46.4–2.7 (2.8–2.7)
Unique reflections 128,689b (12,927) 143,557b (14,350) 116,038b (11,558) 23,645 (2,254)
Observed reflections 405,018 (40,277) 451,051 (44,554) 366,438 (36,051) 76,978 (7,208)
Completenessa (%) 99.4 (99.4) 99.4 (99.3) 99.6 (99.7) 95.6 (91.6)
Rmerge(%)
a,c 4.5 (42.0) 4.4 (42.8) 4.0 (36.9) 4.8 (37.9)
I/<rI>
a 12.4 (2.7) 12.2 (2.8) 13.4 (3.1) 16.7 (3.1)
Multiwavelength anomalous diffraction phasing with SOLVEd
Resolution () Number of Se sites Correlation of local rms density in native Fourier Mean figure of merite Overall Z-score
1.8 9 0.39 0.57 81.9




f (num. of reflections) 0.155 (66,014)
Rfree







Number of amino acids 318
With alternate conformations 13
With poor electron densityi









Waters and heterogens 31.5
Mean atom B-factor anisotropyk
Protein 0.67
Water 0.71
aValues for highest resolution shell are in parentheses.
bScaling procedure treated the Bijvoet-related reflections independently.
cRmerge 5 S|I–<I>|/S<I>, where I is measured intensity of each reflection and <I> is the intensity averaged from multiple observations of symmetry-related reflections.
dStatistics from SOLVE14 for phasing of the MAD data set collected from the SeMet YraM-C crystal.
eMean figure of merit after RESOLVE 5 0.82.
fRwork 5 S |Fo–Fc|/S|Fc|, where Fo and Fc are observed and calculated structure factors respectively. Bijvoet pairs were not used in refinement by REFMAC.
gRfree is the R-factor calculated from 10% of the reflections not included in the refinement.
hValues in parentheses are the number of atoms added in alternate conformations. Water molecules were considered ‘alternate conformations’ when the distance to a
neighboring water was less than 2.5 Å yet made good hydrogen bonds to the protein or other waters.
iSide- or main-chain atoms with electron density <1.0 sigma above the mean of the map.
jAll atoms were refined with anisotropic displacement parameters (ADPs). These are the isotropic equivalent B-factors.
kAnisotropy is the square of the axial ratio of an ellipsoid representing the atom calculated from the ADPs.15
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tion.29 The presence of TPRs in YraM-N was also identi-
fied by the protein fold recognition server 3D-PSSM30
that scored the TPR fold of the yeast vesicular transport
protein sec17 as the best match with 80% confidence.
PSI-Blast searches with the carboxyl-terminal module
YraM-C, comprised of residues 257–575 of YraM,
showed low (10–16% identity) but very significant simi-
larity to PBPs required for small molecule transport sys-
tems in bacteria. These were annotated as ‘‘putative
branched chain amino acid binding proteins" and
included the E. coli leucine/isoleucine/valine-binding pro-
tein (LIVBP, 11% identity) whose structures (with and
without bound amino acid) have been solved.31,32 The
LIVBP fold was also predicted by the 3D-PSSM server.
Figure 1 shows the alignment of YraM-C sequences from
a diverse subset of YraM homologues. The percent iden-
tity between H. influenzae YraM-C and the other sequen-
ces in this alignment ranges from 23 to 62% (30 to 86%
similar). A structure-based alignment with LIVBP is also
shown.
Structure of YraM-C determined
at 1.35 Å resolution
The native and selenium-containing proteins, with
sequence Met-Val-YraM(257–573)-Val-Asp-His6 (Mr 5
35,800), were expressed and purified by metal affinity
and ion exchange chromatography (see Materials and
Methods). Multiwavelength diffraction data of the Se-
containing protein were phased to 1.8 Å resolution by
SOLVE and the complete model was refined to 1.35 Å to
Rwork 5 0.16 and Rfree 5 0.19 (Table I) against diffrac-
tion data collected at the Se absorption peak wavelength
(0.97843 Å). The final model contains YraM-C residues
Ser257–Val573 and Val574, derived from the expression
vector. Thirteen residues were modeled with alternate
conformations. Because electron density was poor for
residues 322, 346–348, 351, 429, 430, and 574, the resi-
dues are presumed to be disordered.
YraM-C is a putative periplasmic binding
protein in an open configuration
As predicted, YraM-C(257-575) adopts a type 1 PBP-
like fold35 comprised of two distinct globular domains
(N- and C-domains) connected by three interdomain
crossovers. The N-domain includes residues 257–359 and
489–559, and the C-domain contains residues 360–488
and 560–573 [Figs. 1 and 2(A)]. The first portion of the
N-domain forms an a/b structure with a five-stranded
parallel b-sheet and three of the four flanking a-helices
before crossing to the C-domain at residue 359 [Fig.
2(B)]. After the polypeptide returns to the N-domain at
residue 490, it forms a solvent-exposed a-helix (498–
506). This is followed by a long helix (511–535) contain-
ing a 1208 kink at residue 528 that lies on the N-domain
sheet to complete the a/b fold. To complete the domain,
a three-stranded antiparallel b-sheet (536-559) joins the
N-domain parallel sheet through two main-chain hydro-
gen bonds. A disulfide bond between residues Cys554
and Cys356 further anchors the three-stranded sheet to
the parallel sheet.
The C-domain is comprised of a seven-stranded,
mixed b-sheet flanked by helices [Fig. 2(C)]. The first
segment (361–488) forms a five-stranded parallel b-sheet
and all of the helices. After crossing to the N-domain to
complete its fold, the polypeptide returns to the C-do-
main to form a final b-hairpin (b14-15) that is antipar-
allel to the parallel sheet.
Several YraM-C homologues contain insertions on one
or more of the exposed loops at the distal ends of the
molecule [Fig. 1, arrows in Fig. 2(A)]. Two of the inserts
are in the N-domain, between residues 286 and 288 (a1-
b2 loop) and between 352 and 355 (b4-b5 loop). The
former insert in Yersinia, E. coli, and Salmonella is 40–70
residues long and rich in Ala, Pro, Val, and Gln (see Fig. 1).
There is another insert of 20–30 residues with similar
amino acid composition in the C-domain between resi-
dues 427 and 431 (a6-b8 loop).
The folds of the YraM-C domains are most similar to
the domains of periplasmic LIVBP, the homologous leu-
cine-specific binding protein (LBP),36 the cytoplasmic
amide-binding domain of the AmiC repressor, and two
eukaryotic binding protein-like domains: hormone bind-
ing domain of the atrial natriuretic peptide receptor and
glutamate receptor (Table II).
Differences between YraM-C and LIVBP are primarily
found in two loops located on the N-domain distal from
Figure 1
Sequence alignment of presumed YraM-C orthologs and structural alignment to LIVBP. Secondary structure representations for YraM are in blue for N-domain and gold
for C-domain. Residues are colored based on degree of conservation calculated by SCORECONS.14 Those in the top 10 percentile are highlighted in red, the next 10
percentile in orange, and the next 10 percentile in yellow. Numbering is for the H. influenzae sequence. Also shown is a structure-based alignment of the LIVBP sequence
with YraM-C with the structurally equivalent residues in bold. Vertical lines between residues in the LIVBP sequence represent residue insertions that were omitted for
clarity. Black circles are LIVBP residues in the ligand-binding region of the N-domain (see text). The sequence and structure-based alignments were calculated with
ClustalX33 and LSQMAN,34 respectively. Species, protein name, and Genbank accession numbers for sequences in the alignment: Hi, Haemophilus influenzae Rd KW20,
HI1655 (16273542); Hs, Haemophilus somnus, LppC (4096758), Pm, Pasteurella multocida, LppC (15602511); Mh, Mannheimia haemolytica, GS60 antigen
(62798901); Yp, Yersinia pestis, YP03548 (16123692); EcK12, Escherichia coli K12, YraM (7466039); St, Salmonella typhimurium LT2, YraM (16766562); Av,
Azotobacter vinelandii, LppC (67086486); Pf, Pseudomonas fluorescens, LppC (77384908); Pa, Pseudomonas aeruginosa (9950656); Sd, Saccharophagus degradans
2-40 (90022787); Xc, Xanthomonas campestris, XCC0711 (21230186).
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the interdomain cleft. The YraM-C a1 helix is shorter by
two turns compared with LIVBP, resulting in a shorter
loop (residues 286–289) to b2. This same loop in several
YraM homologous contains the long insert discussed
above. Helices a11 and a12 are shorter by two turns
causing the loop between them to differ by up to 9 Å
from LIVBP.
On the side of the domain facing the cleft the position
of the b2-a2 loop (residues 296–300) also differs
between the two proteins. This a2 helix is one turn
shorter in YraM-C and lacks the disulfide bond present
in LIVBP and LBP. Between the two domains of YraM-C
is the a10 helix that is more solvent exposed and makes
fewer interactions with the N-domain when compared
with the corresponding region in LIVBP. Also, in the
interdomain region (residues 551–558), LIVBP has a
b-bulge (324–327) compared to the regular b-structure
in YraM-C (556–558). This causes the direction of the
polypeptides to diverge as they enter the C-domain,
possibly causing the different orientation of the C-domain
with respect to the N-domain in the two proteins (see
below).
In YraM-C, the two domains are oriented to form a
wide, open cleft that is similar to the unliganded, open
Figure 2
Cartoon representation of YraM-C (residues 257–573). (A) Stereo view showing the two domains, N-domain in blue and C-domain in gold. Black arrows indicate the
loops where insertions are found in the YraM homologues of several other species (see Fig. 1). The gray arrow is the view of Fig. 4, into the cleft between the domains.
(B) and (C) N-domain and C-domain secondary structures, respectively, are labeled. This and subsequent figures were rendered with MacPyMOL (version 0.99, Delano
Scientific).
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conformations observed in several other PBPs [Fig.
3(A)]. Such proteins are often dynamic and have flexible
hinge regions connecting the two domains. Sometimes
different degrees of hinge bending are observed in differ-
ent crystal forms of the same PBP. Unfortunately, the
hexagonal crystal form of YraM-C has an identical con-
formation to the monoclinic form discussed here (results
not shown). The YraM-C domain arrangement is most
similar to the ‘‘super-open’’ unliganded conformations of
LIVBP31 (Fig. 3(A), PDB 1Z15). When the N-domains
of LIVBP and YraM-C are superimposed, the root mean
square difference between equivalent residues is about
1.7 Å (Table II). In this superposition, the C-domain of
YraM-C is rotated about 15–208 with respect to the C-
domain of LIVBP along an axis perpendicular to the
strands of the b-sheet (away from cleft, i.e., more open).
The YraM-C C-domain is also translated closer to the N-
domain (as much as 5 Å) in the direction perpendicular
to the C-domain b-sheet [Fig. 3(A)].
Differences in the interdomain region may account for
the difference in YraM-C’s domain orientation when
compared with LIVBP. The amino end of the a11 helix
(512–529) in the YraM-C N-domain is longer by 1.5 hel-
ical turns compared to LIVBP. As a result, the a10-a11
loop is closer to the b9-a8 loop of the C-domain [Fig.
2(B)]. A consequence of the close approach of these
loops is the formation of a pronounced pocket (not
shown) in the interdomain hinge region near the C-do-
main. The pocket is formed from residues from both
domains and includes four aromatics: Phe492 and
Tyr511 from the N-domain and Phe486, Tyr563, and
Ile570 from the C-domain. Ser467 and Asp488 are at the
base of this pocket. In this pocket was difference electron
density with peak height >10 standard deviations above
the mean. We modeled the unknown ligand as BME
because it is the only reagent in the crystallization mix
close in size and shape to the difference density. We ori-
ented the thiol group of the BME toward the bottom of
the pocket to form hydrogen bonds of 2.7 Å to the
Asp488 carboxylate and Ser567 OH. Similar short SH-
OH hydrogen bonds have been observed previously.41
Because only two of the residues (Phe486 and Asp488)
in this pocket are conserved in the sequence alignment
(see Fig. 1), it is unknown whether this pocket has func-
tional significance.
Highly conserved residues are located
in cleft between domains
To find regions of YraM-C that are potentially impor-
tant for biological function, we colored the solvent-con-
tact surface in Figure 4 with the most conserved residues
of Figure 1. Most of the highly conserved and exposed
residues are located in the wide cleft between the two
domains. The cleft is 20 Å long (vertical direction in
Fig. 4) and 18 Å wide in the dimension between the two
domains. Most notable is a small pocket at the base of
the cleft surrounded by residues (clockwise) Pro362,
Glu365, Arg558, Leu360, Arg515, and Ser464, with
Figure 3
Comparison of the relative domain orientation of YraM-C and periplasmic
binding proteins. Red is the YraM-C Ca backbone. Black backbones are (A)
LIVBP in unliganded, super-open conformation (PDB ID: 1Z15); and (B) LBP
in closed, leucine-bound conformation (1USK).
Table II
Superpositions of YraM-C domains with structural homologs
PDB
ID









Leucine-binding protein (LBP), unliganded36 1USG 125 18 1.62 112 10 1.77
Leu/Ile/Val-binding protein (LIVBP), unliganded31 1Z15 122 17 1.67 115 9 1.77
Amide repressor AmiC, liganded37 1PEA 122 19 1.92 99 10 1.94
Ribose binding protein, unliganded38 1BA2 88 12 1.88 103 6 1.99
Atrial natriuretic peptide receptor, unliganded39 1DP4 113 20 1.74 94 12 1.68
Metabotropic glutamate receptor, unlliganded40 1EWT 116 13 1.93 92 9 1.92
Superpositions calculated with LSQMAN34.
ar.m.s.d., root mean square of distances in Å between equivalent Ca atoms.
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Asp488, Ile489, and Met 560 at the bottom [Fig. 5(A)].
Ser463, Tyr436, and Val438 form a small side crevice off
the central pocket. The bottom of the cleft is mostly po-
lar (Glu356, Arg558, Ser464, and Arg515) while the N-
domain side [arrow in Fig. 5(A,C)] of the cleft is pre-
dominantly nonpolar (discussed later). The entire cleft is
filled with arrays of water molecules. Near the hinge
region is a bound sulfate hydrogen-bonded to Ser469
and Gln512 (not shown).
Model of YraM-C in a ‘‘closed’’ conformation
Crystal structures of many PBP-like proteins show a
‘‘closed’’ conformation of the cleft with a bound ligand
between the two domains, effectively sequestering it from
bulk solvent.31 However, the degree of domain closure
observed in ligand-bound crystal structures varies, and
may be related to the size of the bound ligand. In the
closed, leucine-bound forms of LBP (PDB 1USK) or
LIVBP (PDB 1Z16), the cavity between the two domains
is relatively small, and completely buried. In contrast, a
subclass of PBPs typified by the ligand-bound structures
of vitamin B-12 binding protein and the iron sidero-
phore binding protein FhuD, have a wide open cleft that
differs only slightly from the respective unliganded form
crystal structures.42,43 These proteins are characterized
by a long a-helix between the two domains that may
rigidify the structure.
YraM-C may also undergo a conformational change
upon binding a putative ligand. To assess which YraM-C
residues would interact with a small molecule ligand, we
modeled a ‘‘closed’’ form of YraM-C by separately super-
posing the N- and C-domains of YraM-C on the corre-
sponding domains of the leucine-bound form of LBP
(PDB id 1USK, Fig. 6).36 We also adjusted the main
chain torsion angles in the hinge regions, residues 358–
361 and 555–559. The closed YraM-C model has a dis-
tinct pocket or cavity in a region corresponding to the
location of the bound leucine in LBP (magenta sphere in
Fig. 6). The cavity is about 16 Å long in the direction
perpendicular to the hinge, 8-Å deep, and 8-Å wide. We
estimate that it is approximately three times larger than
the leucine-binding site in the LBP closed structure. Resi-
dues lining the cavity from the N-domain are predomi-
nantly hydrophobic, and include Leu516, Leu272,
Gln323, Leu320, Ile 276, and Met 519. However, four res-
idues exposed to the cavity are polar and highly con-
served: Asn344, Glu365, Ser464, and Arg515 (see Fig. 6).
Conserved residues Lys322 and Asn344 of the N-do-
main, and Arg393 and Glu363 from the C-domain, are
located on the outer lips of the cleft, Comparison of the
open structure and closed model suggests that these resi-
dues could form interdomain hydrogen bonds upon cleft
closure. These interactions may serve to sequester the
contents of the binding cavity from bulk solvent.
Figure 5
Putative ligand-binding cleft of YraM-C. (A) At the base of the cleft is a pocket
surrounded by residues L360, R515, S464, D365, and R558. Yellow-colored side
chains are the most conserved residues. (B) and (C) show the structurally
equivalent nonpolar surfaces (yellow) on the N-domains of LIVBP and YraM-C,
respectively, viewed approximately in the direction of the violet arrow shown in
(A). As in LIVBP, this surface in YraM-C may serve as an initial interaction
site for a proposed amphipathic ligand. In LIVBP (B), the leucine side chain is
positioned between A100, F276, Y18, and L77 and its amino and carboxylate
groups form hydrogen bonds to T102 and S79.
Figure 4
Conserved residues cluster in the putative ligand-binding cleft of YraM-C. In
gray is the solvent contact surface of YraM-C. Surfaces of conserved side chains
are colored as in Fig. 1. N-domain is on the right and the C-domain is on the
left. See the gray arrow in Fig. 2(A) for the view orientation.
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Similar nonpolar surface in YraM-C
and LIVBP clefts
The proposed ligand-binding site of YraM-C is com-
prised of residues from both domains and has both
hydrophobic and polar regions. Despite fold similarity,
the residues in the YraM-C binding site are not identical
with those in LBP and LIVBP. Structures and kinetic
studies of ligand binding to the maltose-binding protein
(MBP) and LIVBP in various conformations suggest that
ligands bind in two steps: recognition of ligand by one
domain, followed by domain closure.31 In MBP and
LIVBP, the respective ligand binds ‘‘preferentially to the
domain whose site is more nonpolar in character than
that of the other domain.’’31 In LIVBP, this nonpolar
region is found on the surface of the N-domain centered
above Glu22 and surrounded by Leu77, Cys78, Ala100,
and Phe276 [Fig. 5(B)]. At one edge of this region are
two polar residues, Thr102 and Ser79. The amide and
carboxylate of a bound leucine molecule form hydrogen
bonds to these two residues while the side chain is nes-
tled in the hydrophobic pocket.
Interestingly, the N-domain of YraM-C [Fig. 5(C)] has
a very similar region comprised of residues that are
structurally equivalent to those residues in LIVBP men-
tioned earlier. In YraM-C, the hydrophobic pocket is cen-
tered above residue Ile276, and surrounded by Leu320,
Leu321, Leu272, Leu516, and Met519 [Fig. 5(C)], most
of which are conserved in YraM-C homologues. The po-
lar residues are Asn344 and Lys322 and are structurally
equivalent to the polar residues described for LIVBP
above. Black dots in Figure 1 highlight the location of
these residues in both proteins. All of the residues in this
region are also in the ligand-binding site of the modeled
closed form of YraM-C. We anticipate that YraM-C may
bind an amphipathic ligand, and interact with both the
nonpolar surface of the N-domain as well as the polar
side chains contributed by the C-domain.
Location of residues responsible for the
temperature sensitive mutant
The temperature sensitive mutant Asp522?Gly
allowed H. influenzae cells to grow in rich medium at
308C but not at 378C.4 Asp522, identical in all YraM
homologues, is located on the N-domain’s long a11 helix
where it makes three hydrogen bonds to a b-turn (544–
545) between the first and second strands (b11 and b12)
of a three-stranded antiparallel sheet (536–559; Fig. 7).
This small sheet forms part of the hinge region between
the domains. The hydrogen bonds from Asp522 orient
the b-turn and allow it to pack against a predominantly
nonpolar loop, residues 489–491. Loss of these hydrogen
bonds in the Asp522?Gly mutant may increase the dy-
namics of the b-sheet and possibly interfere with hinge
movement or ligand binding.
DISCUSSION
The structure of the carboxyl-terminal module of
YraM is very similar to that of type 1 PBPs.44,45 Like
YraM, the unliganded forms of PBPs show a wide cleft
between the domains and a relatively flexible hinge
Figure 7
Location of Asp522 on a11 of the N-domain. Substitution of Asp522 with Gly
produces a temperature-sensitive mutant that prevents H. influenzae from
growing at 378C but grows normally at 308C. Asp522 forms hydrogen bonds to
the b-turn between strands b11 and b12 (also see Fig. 2(B)). Inset shows that
this region is located between the two YraM-C domains.
Figure 6
The YraM-C putative ligand binding site in a model of the ‘‘closed’’ form based
on the closed, liganded structure of LBP. The conserved residues are colored in
yellow and the N-terminal domain is on the right. The maroon sphere
represents the corresponding location of bound leucine in the LBP structure.
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region. Upon binding their cognate ligands, most PBPs
adopt a conformation in which the two domains close
together to sequester the ligand molecule. For solute
transport, the ‘‘closed’’ PBPs bind to a transmembrane
permease, part of a ABC-type transporter. ATP hydrolysis
by the associated cytoplasmic ATPase in this complex
induces a conformational change that releases the ligand
from the PBP for translocation into the cytoplasm.
PBPs and similarly folded proteins can have other
functions besides transport. Some PBPs serve as initial
chemoreceptors for bacterial chemotaxis.46 Other PBP-
like proteins bind small molecules that then interact
with a bacterial transmembrane receptor to activate a
cytoplasmic sensor kinase as part of two-component sig-
naling systems.47 Cytoplasmic proteins in bacteria and
higher eukaryotes also have PBP folds, such as the
ligand-binding regulatory domains of some transcription
factors (e.g., lac repressor) and an inner membrane-asso-
ciated glycosyltransferase.48 In eukaryotes, the extracellu-
lar module of the transmembrane atrial natriuretic hor-
mone receptor also has the PBP fold but forms dimers.49
The hormone peptide does not bind in the receptor’s
cleft like other PBPs, but binds to a conserved surface
between the two subunits of the dimer.
YraM-C is most similar to the leucine-specific- or Leu/
Ile/Val-binding proteins in the super-open conformation
observed for unliganded LIVBP.31 Despite the similarity,
YraM-C does not bind leucine (B. Tirupati, unpublished
data). Although no bound ligand was observed in the
YraM-C crystal structure, we noted that the majority of
highly conserved residues in YraM orthologs are between
the two domains in the same location where other PBPs
bind their ligands.
PBPs often copurify with their respective ligand allow-
ing identification in the crystal structure (e.g., Ref. 50).
The most likely reason why a putative bound ligand was
not observed in the YraM-C crystal structure is that ei-
ther the appropriate ligand was not present in the E. coli
cytoplasm or growth media, or the ligand dissociated
during purification or crystallization. In support of the
latter hypothesis, we noted that the packing of YraM-C
in the monoclinc crystal form precludes the protein from
assuming the closed form.
We have modeled a putative closed form of the pro-
tein, but the question remains if it is realistic. Normal
modes derived from a molecular dynamics simulation of
LIVBP showed the hinge-bending motion necessary for
adopting the observed closed conformation.31 To see if
YraM-C might have similar dynamics necessary for clos-
ing the interdomain cleft, we analyzed the normal modes
for unliganded LIVBP and YraM-C using the ElNémo
server.51 Both structures displayed the same interdomain
hinge-bending motion necessary for domain closing (data
not shown). From these observations we hypothesize that
YraM-C is a solute binding protein and that ligand bind-
ing will stabilize a ‘‘closed’’ cleft conformation as observed
for the LIVBP structure with bound amino acid [see Fig.
3(B)]. Ongoing experiments to identify this ligand will
contribute to understanding the function of YraM.
Speculations on the function of YraM
Little has been published about the function of YraM
or its homologues other than its identification as an
essential protein in H. influenzae.4 The location of yraM
on the H. influenzae chromosome provides few clues to
its function. YraM is the second in a cluster of five genes
conserved in many Gram-negative genomes. The last
gene in the cluster, HI1658 (E. coli yraP), is also an outer
membrane lipoprotein and was shown to be essential for
growth in H. influenzae.2 In E. coil this protein is regu-
lated by rE and was proposed to be involved in outer
membrane integrity.52
The only gene in the cluster with a well-defined func-
tion is the cytoplasmic HI1657 (E. coli yraO, diaA).
HI1657 was annotated as encoding a phosphoheptose
isomerase similar to GmhA involved in lipopolysaccha-
ride core biosynthesis. Recent studies of the orthologous
E. coli DiaA protein show that the protein is important
for initiation of chromosomal replication.53 It forms a
tight complex with DnaA, enabling the latter to bind and
unwind oriC, the E. coli origin of replication. If this gene
is coregulated with YraM, we might expect YraM to be
involved in some process necessary for cell division.
Although the majority of YraM’s conserved residues
are found in YraM-C (data not shown), the structure of
YraM-N (residues 26–256) may also give clues to YraM’s
function. We predicted that YraM-N contains helix-turn-
helix motifs similar to the TPRs found in a large variety
of other proteins. To the authors’ knowledge, YraM is
unique in having a structure in which this TPR fold is
fused to the amino terminus of a PBP-like molecule.
This novel fusion may be important for protein localiza-
tion, or to enhance the interaction of YraM-C with other
molecules. A similar idea was proposed for the periplas-
mic lytic transglycosylase Slt70.28 Like YraM, SLT70 has
an amino-terminal domain containing 11 TPR motifs,
followed by a functional catalytic domain that is structur-
ally similar to lysozyme. Considering SLT70’s role in the
hydrolysis of glycosidic bonds and turnover of peptido-
glycan, researchers suggested that this amino-terminal
helical domain may have affinity for peptidoglycan.28
Although SLT70 is not a lipoprotein, there are similar
murein hydrolases, such as MltA, MltC, and NlpD, which
are outer membrane lipoproteins.
Because YraM orthologs are not found in Gram-posi-
tive organisms, we speculate that YraM may be involved
in structures specific to Gram-negative bacteria, such as
meso-diaminopimelate peptidocglycan or lipopolysaccha-
ride. If we assume that full-length YraM is tethered on
the inner leaflet of the outer membrane, it is likely within
reach of the peptidoglycan estimated to be 50 Å from
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the membrane.54 There is precedence for binding protein
folds functioning in peptidoglycan biogenesis. For exam-
ple, MppA55 is a PBP that is essential for import of
murein tripeptide and MurG is a cytoplasmic PBP-like
glycosyltransferase required for the biosynthesis of pep-
tidoglycan precursors.48 Interestingly, a model of 1,6-
anhydromuropeptide, which co-crystallized with SLT70,28
will fit in the proposed binding cleft of YraM-C, but
only in the open form (V. J., results not shown).
Although Gram-positive bacteria express PBPs as lipo-
proteins, only a few besides YraM have been described
for Gram-negative bacteria. Interestingly, at least two of
them may bind iron. HbpA is a heme-binding PBP in H.
influenzae, but its role in heme utilization is not fully
understood.56,57 A putative iron-binding periplasmic
lipoprotein SfbA (NlpA) from Salmonella enteritidis was
induced in the presence of iron.58 A recent dissertation,
studying the outer membrane proteome of a clinically
relevant P. aeruginosa, reports that YraM is expressed at
low levels during normal growth in rich media but at
high levels during iron starvation induced by addition of
1.1 mM 2,2-dipyridyl, an iron chelator, to the growth
media.59 This finding may be particularly relevant to H.
influenzae because it must import iron and heme or por-
phyrin for aerobic growth. Interestingly, we note that
HI1654 (yraL in E. coli), just upstream of yraM, encodes
a putative tetrapyrrole methylase. Tetrapyrroles are pre-
cursors of porphyrin biosynthesis. Like YraM, HI1654 is
essential in H. influenzae, but not in E. coli or P. aerugi-
nosa.2 Expression of the P. aeruginosa ortholog of
HI1654 is upregulated in a yraM deletion mutant of P.
aeruginosa (Wong and Akerley, unpublished results), sug-
gesting that the function of these two genes are linked.
These observations may imply a role for YraM in iron or
porphyrin acquisition.
Is YraM part of a binding protein-mediated ligand
transport system? In the ABC transporter system
described earlier, binding proteins are in the periplasm
(or anchored to the inner membrane) and physically
interact with a membrane-bound permease in the cyto-
plasmic membrane. In contrast, YraM is anchored to the
outer membrane. When MalE, a soluble periplasmic
MBP, was modified to be an outer membrane lipopro-
tein, it failed to function in maltose uptake.60 One ex-
planation might be that the size of MalE and the close
proximity of the peptidoglycan prevented its interaction
with the appropriate membrane ABC permease. Results
from electron microscopy54 show the periplasm to be
about 170 Å wide, but recent structures of the type III
secretion system needle61 and the exopolysaccharide
translocation apparatus62 suggest that the width may be
much smaller (125–150 Å). Although the relative orien-
tation of the two modules of YraM is not known, we
estimate that the protein will be too short to interact
with the membrane permease. To circumvent this prob-
lem, the YraM-C portion might be released by proteoly-
sis, a mechanism occasionally observed for other lipopro-
teins. Of course, we cannot rule out that YraM may
function in the transport of molecules across the outer
membrane, perhaps by sequestering ligands in the peri-
plasm. Addressing these possibilities represents a promis-
ing area for future research into the mechanism of
YraM’s function.
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